Next-gen chickpea proteins suited for dairy alternatives
Researchers from the Robert H. Smith Faculty of Agriculture, Food, and Environment of Hebrew University recently developed a line of next-gen chickpea isolates, using patent-pending technology to extract up to 90% pure protein from the chickpea seed. The new line, which is designed to be used in plant-based dairy alternative products, has been launched through a startup called ChickP, founded by Ram Reifen, a pediatric gastroenterologist and director of the Center for Nutrigenomics and Functional Foods at Hebrew University.
“This is a high-quality protein, non-allergenic, non-GMO, and devoid of phytoestrogens, with excellent functionality and thereby suitable to various applications like weaning foods, dairy and meat analogues, supplementation of proteins to athletes, etc.,” explains Reifen.
The new chickpea isolates, which went into production in October 2019, demonstrate several characteristics that help alternative dairy producers overcome challenges in processing. Features include a neutral flavor, smooth texture, emulsion stability, and very low fat content, as well as shorter, cleaner labeling. Thanks to its high solubility and smooth viscosity, ChickP forms an emulsion/gel that also contributes to a firm finished product. According to Reifen, plant-based milk alternatives that contain ChickP have been shown to mimic cow’s milk and yogurt for taste, mouthfeel, and nutritional value.
The next phase of Reifen’s research is twofold. “The additional research conducted now and planned for the future is, on one hand, to look for various applications of the chickpea protein,” he says, “but also, [in] the possible association with chronic inflammatory diseases, we already have some indications for favorable effects.”
Looking for chemical products? Let suppliers reach out to you!
2026-07-08
-
Functional Ingredients Industry Overview
Collection of Markets for Functional Ingredients in Food & Nutrition and Cosmetics.Published in: Mar. 2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Nanotechnology-enabled provide natural alternatives to chemical fertilisers
-
EU Approves Market Entry for Genetically Modified Soybeans MON 87705 × MON 87708 × MON 89788
-
From Fungus to Food: EFSA Greenlights Rhizomucor pusillus Biomass as Safe Novel Ingredient
-
Sun-Kissed Insect Oil? EFSA Approves UV-Treated Mealworm Fat as Safe—and Vitamin D-Rich—Novel Food
-
He Spent 40 Years at Nestlé—Then Was “Cleared Out” Days After Becoming CEO: This Isn’t a Scandal, It’s Capital’s Coldest Face
-
From Kitchen Herb to Feed Additive: EFSA Gives Green Light to Marjoram Oil—With a Caution for Handlers
-
Triple Shield, Zero Risk: EFSA Declares Stacked GM Cotton Safe for Food, Feed, and Environment
-
Red Algae, Golden Promise—With a Daily Dose Warning: EFSA Clears Astaxanthin-Rich Algal Meal for New Foods
-
Cheap Sugar, Costly Lives: WHO Pushes Governments Toward a New Era of Health Taxes
-
Singapore Orders Nestlé Formula Recall as Infant Safety Comes Under the Spotlight
Recommend Reading
-
U.S. EPA Targets Perchlorate: A New Safety Line Drawn in Drinking Water Standards
-
Jell-O Simply Shows Clean Label Reformulation Has Entered Legacy Brands
-
New York’s Food Chemical Disclosure Bill Raises the Bar for GRAS Transparency
-
Dietary Supplement Listing Debate Puts Nutrition Ingredients Under a Brighter Spotlight
-
Spice Up the Coop: EFSA Reaffirms Safety of Botanical Blend for Broiler Feed—With a Warning for Handlers
-
Behind the Three Consecutive Titanium Dioxide Price Hikes, Sulfur and Sulfuric Acid Costs Are Rewriting the Pricing Floor
-
Paint Giant PPG Announces Global Price Hike
-
When Global Buyers Sit at the Same Table, Chinese Suppliers Respond: A Real 1-on-1 Online Business Matching Event
-
After Semaglutide Patent Expiry in India, the Price System Has Been Restructured as More Than 40 Drugmakers Enter the Competition
-
Cost Support Overlaid with Tightening Supply—Melamine Prices Remain Consolidated